These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 38322318)

  • 1. Gut microbiota and its therapeutic implications in tumor microenvironment interactions.
    Feng P; Xue X; Bukhari I; Qiu C; Li Y; Zheng P; Mi Y
    Front Microbiol; 2024; 15():1287077. PubMed ID: 38322318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microenvironment signaling and therapeutics in cancer progression.
    Goenka A; Khan F; Verma B; Sinha P; Dmello CC; Jogalekar MP; Gangadaran P; Ahn BC
    Cancer Commun (Lond); 2023 May; 43(5):525-561. PubMed ID: 37005490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota and tumor-associated macrophages: potential in tumor diagnosis and treatment.
    Zhou D; Li Y
    Gut Microbes; 2023 Dec; 15(2):2276314. PubMed ID: 37943609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies.
    Lu Y; Yuan X; Wang M; He Z; Li H; Wang J; Li Q
    J Hematol Oncol; 2022 Apr; 15(1):47. PubMed ID: 35488243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An emerging strategy: probiotics enhance the effectiveness of tumor immunotherapy via mediating the gut microbiome.
    Jiang S; Ma W; Ma C; Zhang Z; Zhang W; Zhang J
    Gut Microbes; 2024; 16(1):2341717. PubMed ID: 38717360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Influence of the Microbiome on Immunotherapy for Gastroesophageal Cancer.
    Dadgar N; Edlukudige Keshava V; Raj MS; Wagner PL
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
    Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
    Front Immunol; 2020; 11():612202. PubMed ID: 33488618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiota and Tumor Immune Escape: A New Perspective for Improving Tumor Immunotherapy.
    He Y; Huang J; Li Q; Xia W; Zhang C; Liu Z; Xiao J; Yi Z; Deng H; Xiao Z; Hu J; Li H; Zu X; Quan C; Chen J
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.
    Nenkov M; Ma Y; Gaßler N; Chen Y
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota in Tumor Microenvironment: A Critical Regulator in Cancer Initiation and Development as Potential Targets for Chinese Medicine.
    Wang L; Peng F; Peng C; Du JR
    Am J Chin Med; 2021; 49(3):609-626. PubMed ID: 33683187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research Progress and New Immunotherapy Strategies of Tumor Microenvironment Metabolism].
    Peng YM; Luo XM; Chen JY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):505-509. PubMed ID: 37248575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota, an emergent target to shape the efficiency of cancer therapy.
    Kouidhi S; Zidi O; Belkhiria Z; Rais H; Ayadi A; Ben Ayed F; Mosbah A; Cherif A; El Gaaied ABA
    Explor Target Antitumor Ther; 2023; 4(2):240-265. PubMed ID: 37205307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of Gut Microbiota-Derived Metabolites in Tumor Progression and Cancer Therapy.
    Yang Q; Wang B; Zheng Q; Li H; Meng X; Zhou F; Zhang L
    Adv Sci (Weinh); 2023 May; 10(15):e2207366. PubMed ID: 36951547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor microbiome - an integral part of the tumor microenvironment.
    Ciernikova S; Sevcikova A; Stevurkova V; Mego M
    Front Oncol; 2022; 12():1063100. PubMed ID: 36505811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral microbiota: implications for cancer onset, progression, and therapy.
    Wu J; Zhang P; Mei W; Zeng C
    Front Immunol; 2023; 14():1301506. PubMed ID: 38292482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between gut microbiota and metastasis in colorectal cancer: implication of neutrophil extracellular traps.
    Wu J; Dong W; Pan Y; Wang J; Wu M; Yu Y
    Front Immunol; 2023; 14():1296783. PubMed ID: 37936694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome.
    Xue X; Li R; Chen Z; Li G; Liu B; Guo S; Yue Q; Yang S; Xie L; Zhang Y; Zhao J; Tan R
    Front Immunol; 2023; 14():1235827. PubMed ID: 37691931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
    Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
    Front Immunol; 2021; 12():669150. PubMed ID: 34267748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out.
    Conti G; D'Amico F; Fabbrini M; Brigidi P; Barone M; Turroni S
    Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.